Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1 clinical trials · Condition
◉ Watch Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer (NCT07589972) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-20 |
Track Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.